08:00 , Feb 25, 2016 |  BC Innovations  |  Targets & Mechanisms

Borrowing for Zika

While companies and international aid organizations scramble to address the Zika outbreak, the research community is putting its foot on the gas to understand more about the basic biology of the virus, clarify the mechanism...
02:10 , Jun 9, 2015 |  BC Extra  |  Company News

Management tracks

Hematology play Cerus Corp. (NASDAQ:CERS) named Richard Benjamin CMO, effective July 13. Benjamin was CMO for the American Red Cross . RNAi therapeutics company Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) named David-Alexandre Gros SVP and CBO. Gros...
07:00 , Apr 15, 2013 |  BC Week In Review  |  Company News

HemaSure, In-Line Diagnostics, American Red Cross deal

The companies signed a letter of intent with the Red Cross to develop a non-invasive anemia screening device based on In-Line's hematocrit technology. The electronic device would screen blood donors for anemia without the need...
07:00 , Apr 15, 2013 |  BC Week In Review  |  Company News

HemaCare, American Red Cross blood products/substitutes news

The parties settled for undisclosed terms a 1995 lawsuit in which HEMA alleged that Red Cross pricing practices in Los Angeles and Orange counties for platelets and other blood products violated the federal antitrust laws...
07:00 , Sep 17, 2012 |  BC Week In Review  |  Company News

Cerus, American Red Cross, Blood Systems deal

Cerus announced separate deals with the American Red Cross and Blood Systems to commercialize Cerus' Intercept Blood System for plasma to treat thrombotic thrombocytopenic purpura ( TTP ) in the U.S., pending FDA approval. Cerus...
00:09 , Aug 9, 2011 |  BC Extra  |  Politics & Policy

Former NIH director Healy passes away

Bernadine Healy, the first woman to lead NIH, died Saturday. Healy, 67, had suffered from brain cancer. During her service as NIH director from 1991-93, she launched the NIH Women's Health Initiative to study diseases...
07:00 , Oct 12, 2009 |  BC Week In Review  |  Company News

Prometic, American Red Cross deal

ProMetic completed its previously announced deal to acquire the American Red Cross' common stock holdings in the partners' Pathogen Removal and Diagnostic Technologies Inc. JV. The acquisition will increase ProMetic's ownership to 77%. The remaining...
07:00 , Sep 29, 2008 |  BC Week In Review  |  Company News

Aeris, Kuros deal

Kuros granted Aeris an exclusive license to patents covering the delivery of certain drugs in a fibrin sealant for lung volume reduction. Kuros will receive an undisclosed upfront payment and milestones, plus royalties on sales...
07:00 , Apr 14, 2008 |  BC Week In Review  |  Company News

Prometic, American Red Cross deal

ProMetic signed a letter of intent to acquire the American Red Cross' common stock holdings in the partners' Pathogen Removal and Diagnostic Technologies Inc. JV. The acquisition will increase ProMetic's ownership to 77%. The remaining...
07:00 , May 8, 2006 |  BC Week In Review  |  Company News

BioE management update

BioE Inc. , St. Paul, Minn.   Business: Supply/Service, Gene/Cell therapy   Hired: Gayl Chrysler as VP of cellular technologies and clinical affairs, formerly national director of operations for the National American Red Cross' cord...